Hemoglobin levels in African-Americans [1]

Blood

Volumn 107, Issue 5, 2006, Pages 2208-

  Schechter, Geraldine P ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN;

AFRICAN AMERICAN; ANEMIA; DIABETES MELLITUS; ERYTHROCYTOSIS; ETHNIC DIFFERENCE; HEMOGLOBIN DETERMINATION; HEREDITY; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 33344461857     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-3025     Document Type: Letter

References (5)

1. Beutler E, West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volume. Blood. 2005;106:740-745.
2. Marathias KP, Agroyannis B, Mavromoustakos T, Matsoukas J, Vlahakos DV. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Curr Top Med Chem. 2004;4:483-486.
3. Plata R, Cornejo A, Arratia C, et al. Angiotensin converting enzyme inhibition therapy in altitude polycythaemia: a prospective randomized trial. Lancet. 2002;359:663-666.
4. Vlahakos DV, Marathias KP, Agroyannis B, Badias NE. Post transplant erythrocytosis. Kidney Int. 2003;63:1187-1194.
5. Naito M, Kawashima A, Akiba T, Takanashi M, Nihei H. Effects of an angiotensin II receptor antagaonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients. Am J Nephrol. 2003;23:287-293.